Flow Cytometry Market Report 2025

This Flow Cytometry market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The flow cytometry market size has grown strongly in recent years. It will grow from $6.88 billion in 2024 to $7.51 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to immunophenotyping, cancer research, hematology and blood cell analysis, clinical diagnostics, drug discovery and development.

The flow cytometry market size is expected to see rapid growth in the next few years. It will grow to $11.6 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to single-cell analysis, immunotherapy and car-t cell development, infectious disease research, biomarker discovery, point-of-care testing (poct). Major trends in the forecast period include multicolor analysis, automation and robotics, imaging flow cytometry, data analysis and informatics, sample preparation innovations.

The rising global number of HIV cases is a key driver for the flow cytometry market, as this technique plays a direct role in HIV diagnosis. Flow cytometry utilizes light scattering to identify cells, which are labeled with specific markers known as CDs (clusters of differentiation) based on the scattering pattern. For example, in October 2023, the UK Health Security Agency reported a 22% increase in HIV diagnoses in England, rising from 3,118 cases in 2021 to 3,805 in 2022. As the global HIV population continues to rise, the demand for diagnostic methods like flow cytometry is also growing.

The growth in drug launches has also contributed to the expansion of the flow cytometry market. Drug launches involve introducing new pharmaceutical products to the market, following regulatory approval, marketing, and distribution after extensive research and development. Flow cytometry plays a critical role in drug launches by evaluating cellular responses, drug efficacy, and toxicity, ensuring that safe and effective medications are brought to market. It helps with accurate characterizations essential for regulatory approval and post-launch monitoring. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations reported that North America accounted for 52.3% of global pharmaceutical sales in 2022, up from 49.1% in 2021, highlighting a significant market share increase. Thus, the rise in drug launches is driving growth in the flow cytometry market.

Leading companies in the flow cytometry market are concentrating on the development of advanced products, such as research-grade flow cytometers, to improve the sensitivity and resolution of cell analysis. Research-grade flow cytometers are used in scientific studies to examine the physical and chemical properties of cells or particles as they pass through a fluid stream. These devices provide high sensitivity and resolution for multiparametric cellular analysis, featuring advanced optical systems and software that can detect multiple fluorescent markers. They are crucial in fields like immunology, oncology, and cell biology. For example, in March 2024, Beckman Coulter Life Sciences, a US-based company specializing in biomedical testing products, introduced the CytoFLEX nanoflow cytometer. This system is capable of detecting nanoparticles as small as 40 nm, making it highly effective for analyzing extracellular vesicles (EVs) and other nanoscale entities. It offers a sensitivity range from 1 µm to 40 nm, with a resolution of 10 nm, allowing for the detection of low-abundance cargo within EVs. This enhanced sensitivity is crucial for accurately characterizing small particle populations. The system features 6 fluorescent channels and 5 side scatter channels, enabling extensive data collection across multiple parameters simultaneously. It is also equipped with CytExpert nano software, which provides an intuitive interface for simplifying complex analyses while supporting advanced research.

Companies in the flow cytometry market are also focused on developing innovative products such as automated sample preparation systems to deliver faster, more accurate results while reducing hands-on time for technicians. An automated sample preparation system streamlines laboratory processes by automating tasks such as mixing, staining, and dilution, ensuring consistent and precise sample preparation. This not only minimizes manual effort but also enhances efficiency, making it ideal for high-throughput labs and clinical diagnostics. For example, in June 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD FACSDuet. This premium sample preparation system is designed to integrate seamlessly with the BD FACSLyric clinical flow cytometry system, enabling a fully automated “walkaway” workflow. It automates critical processes, including cocktailing, washing, and centrifuging of samples. Once prepared, the samples are transferred to the flow cytometer with no human intervention, reducing manual steps and hands-on time. This system significantly improves standardization and reproducibility in clinical diagnostics, boosting overall lab efficiency.

In February 2022, KCAS Bioanalytical and Biomarker Services, a US-based development service provider compliant with GLP and GCP standards, acquired FlowMetric LLC for an undisclosed amount. This acquisition is expected to bolster KCAS's capabilities in the field of analytical testing. FlowMetric is a US-based provider of flow cytometry and cellular assay services.

Flow cytometry is a technique where cells are introduced into a fluid medium that is passed through a pulsating laser beam. As the cells scatter the laser beam in various directions, receptors capture the light and convert it into data displayed on a monitor. This method is used to analyze biological cell characteristics, such as size, count, and complexity, utilizing laser optics.

Flow cytometry employs different technologies, including cell-based and bead-based methods, with applications spanning oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, and hematology. This technology serves a diverse range of end-users, including hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, as well as other sectors, to advance scientific research and healthcare practices.

The flow cytometry market research report is one of a series of new reports that provides flow cytometry market statistics, including flow cytometry industry global market size, regional shares, competitors with a flow cytometry market share, detailed flow cytometry market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry industry. This flow cytometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the flow cytometry market include Beckman Coulter Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Luminex Corporation, Miltenyi Biotec Ltd., Becton Dickinson and Company, Sysmex Corporation, Merck KGaA, Danaher Corporation, Apogee Flow Systems Ltd., Stratedigm Inc., General Electric Company, EMD Millipore Corporation, Affymetrix Inc., Biomérieux SA, Cytonome St LLC, Enzo Life Sciences Inc., Sony Biotechnology Inc., Life Technologies Corporation, ACEA Biosciences Inc., Takara Bio Inc., Union Biometrica Inc., Cytek Biosciences Inc., Nexcelom Bioscience LLC, Verity Software House Inc., Spectral Cytometry Systems GmbH, InstruNor AS.

North America was the largest region in the flow cytometry market in 2024. Western Europe was the second largest region in the flow cytometry market analysis. The regions covered in the flow cytometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the flow cytometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The flow cytometry market includes revenue earned by cytometry systems, panel builders, and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.